Mesothelioma Clinical Trials: AZD2171

Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.

If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.

Researchers at the University of Chicago and the National Cancer Institute are recruiting patients diagnosed with mesothelioma for a study of an experimental drug known as AZD2171. The drug is being tested in patients with tumors that cannot be surgically removed.

In this Phase II study, researchers will study the effectiveness of the drug in stopping the growth of tumor cells.

The study is being conducted at 19 hospitals located in the following states: California, Illinois, Indiana, Michigan, Pennsylvania and Wisconsin. More information can be obtained by contacting Hedy L. Kindler, M.D. at the University of Chicago. The study is also being conducted at the Princess Margaret Hospital in Toronto, Ontario, where the primary contact is Natasha Leighl, M.D.

Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.

If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.